Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
Brennan DJ, Rexhepaj E, O'Brien SL, McSherry E, O'Connor DP, Fagan A, Culhane AC, Higgins DG, Jirstrom K, Millikan RC, Landberg G, Duffy MJ, Hewitt SM, Gallagher WM.
Brennan DJ, et al. Among authors: rexhepaj e.
Clin Cancer Res. 2008 May 1;14(9):2681-9. doi: 10.1158/1078-0432.CCR-07-1760.
Clin Cancer Res. 2008.
PMID: 18451232
Free PMC article.